Protalix BioTherapeutics
| Use attributes for filter ! | |
| Stock price | PLX |
|---|---|
| Disclaimer | |
| Headquarters | Karmiel |
| Israel | |
| Founders | Yoseph Shaaltiel |
| Founded | 1993 |
| Subsidiary | Protalix Ltd |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1165130 |
About Protalix BioTherapeutics
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U. S. Food and Drug Administration approval for the treatment of Gaucher disease.
